Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission
ClinicalTrials.gov study NCT03337568. IPD Sharing: NO. Countries: 1. Publications: 3.
Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML
ClinicalTrials.gov study NCT02094794. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients
ClinicalTrials.gov study NCT01999413. IPD Sharing: NO. Countries: 1. Publications: 3.
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03568994. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL)
ClinicalTrials.gov study NCT06499025. IPD Sharing: NO. Countries: 1. Publications: 6.
Enhanced Palliative Care in MDS and AML
ClinicalTrials.gov study NCT04226768. IPD Sharing: NO. Countries: 1. Publications: 25.
A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy
ClinicalTrials.gov study NCT03310918. IPD Sharing: NO. Countries: 1. Publications: 1.
Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)
ClinicalTrials.gov study NCT02494167. IPD Sharing: NO. Countries: 1. Publications: 1.
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
ClinicalTrials.gov study NCT03150134. IPD Sharing: YES. Countries: 1. Publications: 10.
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML
ClinicalTrials.gov study NCT04722952. IPD Sharing: NO. Countries: 1. Publications: 11.
Epigenetic Reprogramming in Relapse AML
ClinicalTrials.gov study NCT02412475. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML
ClinicalTrials.gov study NCT05404516. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT01994837. IPD Sharing: Not stated. Countries: 0. Publications: 1.
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00153582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AML
ClinicalTrials.gov study NCT03719183. IPD Sharing: UNDECIDED. Countries: 1. Publications: 12.
A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML
ClinicalTrials.gov study NCT04038437. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice
ClinicalTrials.gov study NCT02698124. IPD Sharing: NO. Countries: 1. Publications: 6.
Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML
ClinicalTrials.gov study NCT01161550. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
ClinicalTrials.gov study NCT00687323. IPD Sharing: YES. Countries: 0. Publications: 1.
CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML
ClinicalTrials.gov study NCT03384225. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.